SPY334.57+0.24 0.07%
DIA274.62+0.72 0.26%
IXIC11,010.98-97.09 -0.87%

Baird Initiates Coverage On Immunovant with Outperform Rating

Baird initiates coverage on Immunovant (NASDAQ:IMVT) with a Outperform rating.

Benzinga · -

Baird initiates coverage on Immunovant (NASDAQ:IMVT) with a Outperform rating.